IRIDEX Corporation (United States) is listed on the Nasdaq and has a market capitalization of $14.89 million, with shareholders equity totaling $3.64 million.
The company employs approximately 128 people and operates in the Health sector, within the Medical Supplies and Equipment industry.
Over the past 12 months, IRIDEX Corporation reported $51.57 million in revenue, generating net income of $-3.55 million.
Key financial metrics include a P/E ratio of -4.20, a price-to-book (P/B) ratio of 4.09, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker IRIX.